1.
Perkampus, H.-H. UV-VIS
Spectroscopy and Its Applications; Springer Berlin Heidelberg: S.l., 2013.
2.
Owen, T.; Technologies,
A. Fundamentals of UV-Visible Spectroscopy: A Primer; Agilent Technologies,
2000.
3.
Behera, S. UV-Visible
Spectrophotometric Method Development and Validation of Assay of Paracetamol
Tablet Formulation. J. Anal. Bioanal. Tech. 2012, 03 (06). https://doi.org/10.4172/2155-9872.1000151.
4.
Beckett, A. H.; Stenlake,
J. B. Practical Pharmaceutical Chemistry. Part Two, 4th ed.; CBS Publishers:
New Delhi, India, 1988.
5.
HPLC for Pharmaceutical
Scientists; Kazakevich, Y., LoBrutto, R., Eds.; Wiley-Interscience: Hoboken,
N.J, 2007.
6.
Bélanger, J. M. R.;
Jocelyn Paré, J. R.; Sigouin, M. Chapter 2 High Performance Liquid
Chromatography (HPLC): Principles and Applications. In Techniques and
Instrumentation in Analytical Chemistry; Elsevier, 1997; Vol. 18, pp 37–59.
https://doi.org/10.1016/S0167-9244(97)80011-X.
7.
Mohammed El Amine, M.; E.
Ghanjaoui, A.; Mandil, A.; Ait Sidi Mou, A.; Slimani, R. High Performance
Liquid Chromatography Quality Control. Int. J. Adv. Chem. 2020, 8 (1), 160.
https://doi.org/10.14419/ijac.v8i1.30723.
8.
High Performance Liquid
Chromatography: A Short Review. 2009.
9.
Arup, U.; Ekman, S.;
Lindblom, L.; Mattsson, J.-E. High Performance Thin Layer Chromatography
(HPTLC), an Improved Technique for Screening Lichen Substances. The
Lichenologist.
10. Sethi,
P. D. HPTLC: High Performance Thin-Layer Chromatography ; Quantitative Analysis
of Pharmaceutical Formulations, 1. ed.; CBS Publishers & Distributors: New
Delhi, 1996.
11. Kasture,
A. V. Pharmaceutical Analysis; Pragati Book Corner: Mumbai, 2007.
12. Hussain,
S. Z.; Maqbool, K.; Naseer, B. (PDF) High Performance Thin Layer
Chromatography: Principle, Working and Applications. Int. J. Res. Pharm. Pharm.
Sci. 2019, 4 (3), 83–88.
13. Jain,
A.; Parashar, A. K.; Nema, R. K.; Narsinghani, T. High Performance Thin Layer
Chromatography (HPTLC): A Modern Analytical Tool for Chemical Analysis. Curr.
Res. Pharm. Sci.
14. Srivastava,
M. High-Performance Thin-Layer Chromatography (HPTLC); Springer: Berlin Heidelberg,
2011.
15. Puskuri,
D.; Sathishkumar, D. . M.; Malik, Dr. A.; Jyothi, Dr. N. A Review on
Performance Thin Layer Chromatography. EPRA Int. J. Res. Dev. IJRD 2021, 6
(10). https://doi.org/10.36713/epra2016.
16. Ravisankar,
P.; Navya, C. N.; Pravallika, D.; Sri, D. N. A Review on Step-by-Step
Analytical Method Validation.
17. Research,
C. for D. E. and. Q2(R1) Validation of Analytical Procedures: Text and
Methodology Guidance for Industry. U.S. Food and Drug Administration.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2r1-validation-analytical-procedures-text-and-methodology-guidance-industry
(accessed 2023-03-04).
18. Understanding
and Implementing Efficient Analytical Methods Development and Validation PDF
from AAI Development Services. https://www.pharmaceuticalonline.com/doc/understanding-and-implementing-efficient-anal-0002
(accessed 2023-03-04).
19. Rina,
R.; Baile, M.; Jain, A. A Review: Analytical Method Development and Validation.
2021, 12 (8).
20. Riley,
C. M.; Rosanske, T. W. Development and Validation of Analytical Methods, 1st
edition.; Elsevier, 1996, 1996; Vol. 3.
21. Mayuri,
D.; Ravindranath, S. Analytical Method Development and Validation: A Review. J.
Drug Deliv.
22. The
Nervous System: Central Nervous System Drugs; Root, W. S., Hofmann, F. G.,
Eds.; Academic Press: Amsterdam, 2017.
23. Antiemetics:
What Are They, How Do They Work, What Are They Used For, and More | Osmosis.
https://www.osmosis.org/answers/antiemetics (accessed 2023-03-04).
24. Athavale,
A.; Athavale, T.; Roberts, D. M. Antiemetic Drugs: What to Prescribe and When.
Aust. Prescr. 2020, 43 (2), 49. https://doi.org/10.18773/austprescr.2020.011.
25. Foda,
N. H. Quantitative Analysis of Metoclopramide in Tablet Formulations by Hplc.
Anal. Lett. 1994, 27 (3), 549–559. https://doi.org/10.1080/00032719408001094.
26. Slørdal,
L.; Prytz, P. S.; Aasebø, U.; Aarbakke, J. A Simple HPLC Method for Measuring
Metoclopramide in Serum. Acta Pharmacol. Toxicol. (Copenh.) 2009, 58 (3),
240–242. https://doi.org/10.1111/j.1600-0773.1986.tb00101.x.
27. Khan,
A.; Naqvi, S. B. S.; Shoaib, M. H.; Yousaf, R. I.; Khan, J.; Hanif, M.; Madni,
A. Validation and Application of RP-HPLC Method for the Quantification of
Metoclopramide Hydrochloride in Oral Formulations Prepared for IVIVC Studies.
Pak J Pharm Sci 2012.
28. Bryson,
S. M.; McGovern, E. M.; Gilbert, L. M. Evaluation of a High Pressure Liquid
Chromatographic Technique For Metoclopramide Analysis. J. Clin. Pharm. Ther.
1984, 9 (3), 263–266. https://doi.org/10.1111/j.1365-2710.1984.tb01086.x.
29. Kahali,
N.; Khanam, J. A Novel HPLC Method Validation Based on Analytical Techniques of
Metoclopramide Benzamide Derivative (Metoclopramide Base) and Its Determination
from Solid Dispersion by Solvent Evaporation Method. J. Appl. Pharm. Sci. 2018.
https://doi.org/10.7324/JAPS.2018.8203.
30. Suparna,
S.; Kumar, S. A.; Ompal, S.; Kumar, C. A.; Vikrant, V.; Kumar, A. R.; Kumar, S.
U. RP-HPLC Method Devlopment and Validation of Domperidone in Solid Dosage
Form. 2012, 1 (4).
31. Michaud,
V.; Simard, C.; Turgeon, J. An Improved HPLC Assay with Fluorescence Detection
for the Determination of Domperidone and Three Major Metabolites for
Application to in Vitro Drug Metabolism Studies. J. Chromatogr. B 2007, 852
(1–2), 611–616. https://doi.org/10.1016/j.jchromb.2007.02.044.
32. Yeniceli,
D.; Dogrukol-Ak, D.; Tuncel, M. A Validated HPLC Method with Fluorescence
Detection for the Determination of Droperidol in Pharmaceutical Tablets, Human
Serum, and Human Milk. Chromatographia 2007, 66 (S1), 37–43.
https://doi.org/10.1365/s10337-007-0255-1.
33. Fang,
J.; Gorrod, J. W. High-Performance Liquid Chromatographic Method for the
Detection and Quantitation of Haloperidol and Seven of Its Metabolites in
Microsomal Preparations. J. Chromatogr. B. Biomed. Sci. App. 1993, 614 (2),
267–273. https://doi.org/10.1016/0378-4347(93)80318-X.
34. Lew,
A.; Gao, Q.; Takahashi, L. H. Analysis and Identification of Prochlorperazine
Impurities and Degradation Products Using a Stability-indicating HPLC Method.
J. Liq. Chromatogr. Relat. Technol. 2011, 34 (8), 634–651.
https://doi.org/10.1080/10826076.2011.558650.
35. Houin,
G.; Bree, F.; Lerumeur, N.; Tillement, J. P. High-Performance Liquid
Chromatographic Determination of Alizapride, a New Antiemetic Compound, and Its
Application to a Dose-Dependent Pharmacokinetic Study. J. Pharm. Sci. 1983, 72
(1), 71–74. https://doi.org/10.1002/jps.2600720117.
36. Yasir,
M.; Sara, U. V. S.; Som, I. Development of a New HPLC Method for in Vitro and
in Vivo Studies of Haloperidol in Solid Lipid Nanoparticles. Braz. J. Pharm.
Sci. 2017, 53 (2). https://doi.org/10.1590/s2175-97902017000216047.
37. Deshmukh,
T. B.; Deo, S. S.; Inam, F.; Lambat, T. L.; Gurubaxani, S. B.; Choudhari, A. V.
Development and validation of Ondansetron Hydrochloride in Pharmaceutical
dosage form by RP- HPLC Method. No. 1.
38. Ali,
I.; Gupta, V. K.; Singh, P.; Pant, H. V. Screening of Domperidone in Wastewater
by High Performance Liquid Chromatography and Solid Phase Extraction Methods.
Talanta 2006, 68 (3), 928–931. https://doi.org/10.1016/j.talanta.2005.06.027.
39. Janicki,
C. A.; Ko, C. Y. Haloperidol. In Analytical Profiles of Drug Substances;
Florey, K., Ed.; Academic Press, 1981; Vol. 9, pp 341–369.
https://doi.org/10.1016/S0099-5428(08)60146-X.
40. Angelo,
H. R.; Herrstedt, J.; Jørgensen, M. High-Performance Liquid Chromatographic
Method with Fluorescence Detection for the Simultaneous Determination of
Metopimazine and Its Acid Metabolite in Serum. J. Chromatogr. B. Biomed. Sci.
App. 1989, 496, 472–477. https://doi.org/10.1016/S0378-4347(00)82597-9.
41. Naguib,
I. A.; Abdelrahman, M. M. Stability Indicating HPTLC Method for Determination
of Metopimazine in Pharmaceutical Formulation and Human Plasma. Beni-Suef Univ.
J. Basic Appl. Sci. 2014, 3 (1), 52–62.
https://doi.org/10.1016/j.bjbas.2014.02.007.
42. Karicherla,
V.; Phani, K.; Bodireddy, M. R.; Prashanth, K. B.; Gajula, M. R.; Pramod, K. A
Simple and Commercially Viable Process for Improved Yields of Metopimazine, a
Dopamine D2-Receptor Antagonist. Org. Process Res. Dev. 2017, 21 (5), 720–731.
https://doi.org/10.1021/acs.oprd.7b00052.
43. Croom,
K. F.; Keating, G. M. Metopimazine: A Review of Its Use in the Treatment of
Chemotherapy-Induced Nausea and Vomiting. Am. J. Cancer 2006, 5 (2), 123–136.
https://doi.org/10.2165/00024669-200605020-00006.
44. Mallet,
E.; Bounoure, F.; Skiba, M.; Saussereau, E.; Goullé, J.-P.; Castanet, M.
Pharmacokinetic Study of Metopimazine by Oral Route in Children. Pharmacol.
Res. Perspect. 2015, 3 (3), e00130. https://doi.org/10.1002/prp2.130.
45. Herrstedt,
J.; Angelo, H. R.; Kampmann, J. P.; Hansen, M. Dose-Finding Study of Oral
Metopimazine.
46. Kumar,
A.; Kumar, A. Antiemetics: A Review. 4.
47. Husain,
A. Forced Degradation Studies. J. Anal. Pharm. Res. 2016, 3 (6).
https://doi.org/10.15406/japlr.2016.03.00073.
48. Deokate,
U. A.; Gorde, A. M. Forced Degradation and Stability Testing: Strategies and
Analytical Perspectives. 2 (6).
49. Sharma,
M. K.; Murugesan, M. Forced Degradation Study an Essential Approach to Develop
Stability Indicating Method. J. Chromatogr. Sep. Tech. 2017, 08 (01).
https://doi.org/10.4172/2157-7064.1000349.